U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H36O5
Molecular Weight 404.5396
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EPILOVASTATIN

SMILES

[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]3C[C@@H](O)CC(=O)O3)OC(=O)[C@H](C)CC

InChI

InChIKey=PCZOHLXUXFIOCF-YPQFMRJXSA-N
InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15+,16-,18+,19+,20-,21-,23-/m0/s1

HIDE SMILES / InChI

Description

Epilovastatin is a Lovastatin impurity (Simvastatin Impurity F).

Approval Year

Unknown
139594
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Patents

Patents

US20070087050A1
1
US20070117996
1
US6472542
1
US6995277
1

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Name Type Language
EPILOVASTATIN
Common Name English
BUTANOIC ACID, 2-METHYL-, (1S,3R,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-((2R,4R)-TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER, (2R)-
Systematic Name English
SIMVASTATIN IMPURITY, EPILOVASTATIN- [USP IMPURITY]
Common Name English
(1S,3R,7S,8S,8AR)-8-(2-((2R,4R)-4-HYDROXY-6-OXOTETRAHYDRO-2H-PYRAN-2-YL)ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL (2R)-2-METHYLBUTANOATE
Systematic Name English
SIMVASTATIN IMPURITY F [EP IMPURITY]
Common Name English
Code System Code Type Description
PUBCHEM
40785065
Created by admin on Sat Dec 16 08:29:07 GMT 2023 , Edited by admin on Sat Dec 16 08:29:07 GMT 2023
PRIMARY
EPA CompTox
DTXSID401317715
Created by admin on Sat Dec 16 08:29:07 GMT 2023 , Edited by admin on Sat Dec 16 08:29:07 GMT 2023
PRIMARY
FDA UNII
S9XFL13C1F
Created by admin on Sat Dec 16 08:29:07 GMT 2023 , Edited by admin on Sat Dec 16 08:29:07 GMT 2023
PRIMARY
CAS
79952-44-6
Created by admin on Sat Dec 16 08:29:07 GMT 2023 , Edited by admin on Sat Dec 16 08:29:07 GMT 2023
PRIMARY
SUBSTANCE RECORD
Structure of EPILOVASTATIN
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966